organic compounds
1-(2-Chloroethyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one
aDepartment of Chemistry, Karnatak University, Dharwad 580 003, India, and bDepartment of Studies in Chemistry, Bangalore University, Bangalore 560 001, Karnataka, India
*Correspondence e-mail: dr_imk@yahoo.com
In the title compound, C7H7ClN4O, the pyrazolopyrimidine ring is essentially planar, the r.m.s. deviation of the fitted atoms being 0.0071 Å. The features strong N—H⋯O hydrogen bonds and further consolidated by weak C—H⋯O, C—H⋯N and C—H⋯Cl interactions.
Related literature
For the biological activity of pyrazolopyrimidines, see: Carraro et al. (2006). For a related structure, see: Dolzhenko et al. (2009). For the graph-set analysis of hydrogen bonding, see: Bernstein et al. (1995).
Experimental
Crystal data
|
Refinement
|
Data collection: SMART (Bruker, 1998); cell SAINT-Plus (Bruker, 1998); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and CAMERON (Watkin et al., 1996); software used to prepare material for publication: WinGX (Farrugia, 1999).
Supporting information
https://doi.org/10.1107/S1600536812025184/pv2552sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536812025184/pv2552Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S1600536812025184/pv2552Isup3.cml
A mixture of 5-amino-1-(2-chloro-ethyl)-1H-pyrazole-4-carbonitrile (1 g, 5.8 mmol) and formic acid (15 ml) was heated under reflux for 10 h. The excess of formic acid was removed under reduced pressure and the solid separated was washed with water and recrystallized from ethanol. (Yield = 0.86 g, 75% and m.p. = 470–472 K).
The H atoms were placed at calculated positions in the riding model approximation with N—H = 0.86 Å and C—H = 0.93, and 0.97 Å for aryl and methylene H-atoms respectively, with Uiso(H) = 1.2Ueq(N/C).
Pyrazolo[3,4-d]pyrimidines are purine analogues which exhibit a number of pharmacological properties such as antitryproliferative (Carraro et al., 2006).
In the title compound (Fig. 1), the fused pyrazolopyrimidine ring is substituted with 2-chloro-ethyl group on one side and the oxo group on the other side. The pyrazolopyrimidine ring is planar with the maximum deviation from the mean statistical plane being 0.0115 (14) Å for C3. The cis orientation of 2-chloro-ethyl group with respect to the C2—N2 bond is described by the torsion angle N2—C2—N3—C3, -2.204 (4)°.
The
is stabilized by some interesting features that comprise of intermolecular N—H···O, C—H···O, C—H···N and C—H···Cl interactions (Fig. 2 and Tab. 1). The C—H···O and the N—H···O interactions result in centrosymmetric head-to-head dimers corresponding to the graph set R22(10) and R22(8) motif (Bernstein et al., 1995). There are two types of C—H···N interactions, one of which forms a helix, the other forms sheets along the crystallographic b-axis. The C—H···Cl intermolecular interaction result in one dimensional molecular chain along b-axis. The bond lengths and bond angles in the title molecule agree very well with the corresponding bond distances and bond angles reported in a closely related compound (Dolzhenko et al., 2009).For the biological activity of pyrazolopyrimidines, see: Carraro et al. (2006). For a related structure, see: Dolzhenko et al. (2009). For the graph-set analysis of hydrogen bonding, see: Bernstein et al. (1995).
Data collection: SMART (Bruker, 1998); cell
SAINT-Plus (Bruker, 1998); data reduction: SAINT-Plus (Bruker, 1998); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and CAMERON (Watkin et al., 1996); software used to prepare material for publication: WinGX (Farrugia, 1999).C7H7ClN4O | F(000) = 416 |
Mr = 198.61 | Dx = 1.565 Mg m−3 |
Monoclinic, P21/n | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2yn | Cell parameters from 1548 reflections |
a = 4.6448 (1) Å | θ = 1.8–25.2° |
b = 8.0792 (1) Å | µ = 0.41 mm−1 |
c = 22.7335 (4) Å | T = 296 K |
β = 93.554 (1)° | Block, yellow |
V = 851.46 (3) Å3 | 0.18 × 0.16 × 0.16 mm |
Z = 4 |
Bruker SMART APEX CCD detector diffractometer | 1548 independent reflections |
Radiation source: fine-focus sealed tube | 1353 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.023 |
ω scans | θmax = 25.2°, θmin = 1.8° |
Absorption correction: multi-scan (SADABS; Bruker, 1998) | h = −5→5 |
Tmin = 0.930, Tmax = 0.937 | k = −9→9 |
7660 measured reflections | l = −27→25 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.035 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.100 | H-atom parameters constrained |
S = 0.87 | w = 1/[σ2(Fo2) + (0.0642P)2 + 0.5291P] where P = (Fo2 + 2Fc2)/3 |
1548 reflections | (Δ/σ)max = 0.001 |
118 parameters | Δρmax = 0.19 e Å−3 |
0 restraints | Δρmin = −0.37 e Å−3 |
C7H7ClN4O | V = 851.46 (3) Å3 |
Mr = 198.61 | Z = 4 |
Monoclinic, P21/n | Mo Kα radiation |
a = 4.6448 (1) Å | µ = 0.41 mm−1 |
b = 8.0792 (1) Å | T = 296 K |
c = 22.7335 (4) Å | 0.18 × 0.16 × 0.16 mm |
β = 93.554 (1)° |
Bruker SMART APEX CCD detector diffractometer | 1548 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 1998) | 1353 reflections with I > 2σ(I) |
Tmin = 0.930, Tmax = 0.937 | Rint = 0.023 |
7660 measured reflections |
R[F2 > 2σ(F2)] = 0.035 | 0 restraints |
wR(F2) = 0.100 | H-atom parameters constrained |
S = 0.87 | Δρmax = 0.19 e Å−3 |
1548 reflections | Δρmin = −0.37 e Å−3 |
118 parameters |
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
Cl1 | 0.89765 (12) | 0.64259 (8) | 0.72864 (2) | 0.0600 (2) | |
O1 | 0.5103 (3) | 0.78930 (17) | 0.99906 (6) | 0.0516 (4) | |
N1 | 0.7733 (3) | 0.95763 (18) | 0.94256 (6) | 0.0381 (4) | |
H1 | 0.7021 | 1.0429 | 0.9590 | 0.046* | |
N2 | 1.0887 (3) | 0.86963 (19) | 0.87124 (7) | 0.0396 (4) | |
N3 | 1.0967 (3) | 0.57267 (18) | 0.86397 (6) | 0.0376 (4) | |
N4 | 0.9763 (3) | 0.43809 (19) | 0.88974 (7) | 0.0434 (4) | |
C5 | 0.9640 (4) | 0.9842 (2) | 0.90068 (8) | 0.0401 (4) | |
H5A | 1.0092 | 1.0935 | 0.8924 | 0.048* | |
C6 | 1.0057 (4) | 0.7151 (2) | 0.88711 (7) | 0.0331 (4) | |
C1 | 1.2904 (4) | 0.5504 (3) | 0.81692 (8) | 0.0418 (4) | |
H1A | 1.4385 | 0.4711 | 0.8295 | 0.050* | |
H1B | 1.3848 | 0.6548 | 0.8096 | 0.050* | |
C2 | 1.1398 (4) | 0.4907 (2) | 0.76054 (8) | 0.0442 (5) | |
H2A | 1.0330 | 0.3907 | 0.7683 | 0.053* | |
H2B | 1.2826 | 0.4635 | 0.7327 | 0.053* | |
C4 | 0.6848 (4) | 0.8026 (2) | 0.96076 (7) | 0.0371 (4) | |
C7 | 0.8174 (4) | 0.6729 (2) | 0.92974 (7) | 0.0349 (4) | |
C3 | 0.8092 (4) | 0.4993 (2) | 0.92932 (8) | 0.0424 (4) | |
H3 | 0.7002 | 0.4356 | 0.9538 | 0.051* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.0545 (3) | 0.0640 (4) | 0.0607 (4) | 0.0019 (2) | −0.0027 (3) | 0.0011 (3) |
O1 | 0.0692 (9) | 0.0403 (8) | 0.0488 (8) | −0.0011 (6) | 0.0335 (7) | −0.0006 (6) |
N1 | 0.0486 (8) | 0.0314 (8) | 0.0355 (8) | 0.0000 (6) | 0.0122 (6) | −0.0036 (6) |
N2 | 0.0475 (9) | 0.0357 (8) | 0.0370 (8) | −0.0044 (7) | 0.0137 (7) | −0.0006 (6) |
N3 | 0.0437 (8) | 0.0351 (8) | 0.0354 (8) | 0.0002 (6) | 0.0121 (6) | −0.0014 (6) |
N4 | 0.0550 (9) | 0.0326 (8) | 0.0436 (9) | 0.0000 (7) | 0.0117 (7) | 0.0026 (7) |
C5 | 0.0489 (10) | 0.0352 (10) | 0.0372 (9) | −0.0061 (8) | 0.0098 (8) | 0.0021 (8) |
C6 | 0.0360 (9) | 0.0343 (9) | 0.0295 (8) | −0.0008 (7) | 0.0060 (7) | −0.0005 (7) |
C1 | 0.0397 (9) | 0.0451 (11) | 0.0418 (10) | 0.0050 (8) | 0.0132 (8) | −0.0037 (8) |
C2 | 0.0505 (11) | 0.0395 (11) | 0.0442 (10) | 0.0004 (8) | 0.0159 (8) | −0.0060 (8) |
C4 | 0.0452 (10) | 0.0365 (10) | 0.0304 (9) | −0.0030 (8) | 0.0088 (7) | −0.0002 (7) |
C7 | 0.0413 (9) | 0.0347 (9) | 0.0293 (8) | −0.0019 (7) | 0.0076 (7) | 0.0006 (7) |
C3 | 0.0528 (11) | 0.0364 (10) | 0.0393 (10) | −0.0025 (8) | 0.0141 (8) | 0.0033 (8) |
Cl1—C2 | 1.788 (2) | C5—H5A | 0.9300 |
O1—C4 | 1.231 (2) | C6—C7 | 1.388 (2) |
N1—C5 | 1.357 (2) | C1—C2 | 1.501 (3) |
N1—C4 | 1.389 (2) | C1—H1A | 0.9700 |
N1—H1 | 0.8600 | C1—H1B | 0.9700 |
N2—C5 | 1.299 (2) | C2—H2A | 0.9700 |
N2—C6 | 1.362 (2) | C2—H2B | 0.9700 |
N3—C6 | 1.344 (2) | C4—C7 | 1.424 (2) |
N3—N4 | 1.371 (2) | C7—C3 | 1.403 (3) |
N3—C1 | 1.451 (2) | C3—H3 | 0.9300 |
N4—C3 | 1.320 (2) | ||
C5—N1—C4 | 124.71 (15) | C2—C1—H1B | 109.0 |
C5—N1—H1 | 117.6 | H1A—C1—H1B | 107.8 |
C4—N1—H1 | 117.6 | C1—C2—Cl1 | 112.00 (14) |
C5—N2—C6 | 111.97 (15) | C1—C2—H2A | 109.2 |
C6—N3—N4 | 111.42 (13) | Cl1—C2—H2A | 109.2 |
C6—N3—C1 | 128.26 (15) | C1—C2—H2B | 109.2 |
N4—N3—C1 | 120.30 (15) | Cl1—C2—H2B | 109.2 |
C3—N4—N3 | 105.48 (15) | H2A—C2—H2B | 107.9 |
N2—C5—N1 | 125.45 (17) | O1—C4—N1 | 120.63 (16) |
N2—C5—H5A | 117.3 | O1—C4—C7 | 127.58 (17) |
N1—C5—H5A | 117.3 | N1—C4—C7 | 111.79 (14) |
N3—C6—N2 | 125.45 (15) | C6—C7—C3 | 105.00 (16) |
N3—C6—C7 | 106.86 (15) | C6—C7—C4 | 118.38 (16) |
N2—C6—C7 | 127.68 (16) | C3—C7—C4 | 136.61 (17) |
N3—C1—C2 | 113.08 (15) | N4—C3—C7 | 111.23 (16) |
N3—C1—H1A | 109.0 | N4—C3—H3 | 124.4 |
C2—C1—H1A | 109.0 | C7—C3—H3 | 124.4 |
N3—C1—H1B | 109.0 | ||
C6—N3—N4—C3 | −0.1 (2) | C5—N1—C4—O1 | −179.89 (18) |
C1—N3—N4—C3 | −178.72 (16) | C5—N1—C4—C7 | −0.4 (2) |
C6—N2—C5—N1 | 0.1 (3) | N3—C6—C7—C3 | 0.2 (2) |
C4—N1—C5—N2 | 0.7 (3) | N2—C6—C7—C3 | −179.13 (18) |
N4—N3—C6—N2 | 179.28 (17) | N3—C6—C7—C4 | −179.02 (15) |
C1—N3—C6—N2 | −2.2 (3) | N2—C6—C7—C4 | 1.6 (3) |
N4—N3—C6—C7 | −0.1 (2) | O1—C4—C7—C6 | 178.81 (19) |
C1—N3—C6—C7 | 178.40 (17) | N1—C4—C7—C6 | −0.6 (2) |
C5—N2—C6—N3 | 179.47 (17) | O1—C4—C7—C3 | −0.1 (4) |
C5—N2—C6—C7 | −1.3 (3) | N1—C4—C7—C3 | −179.6 (2) |
C6—N3—C1—C2 | −108.1 (2) | N3—N4—C3—C7 | 0.2 (2) |
N4—N3—C1—C2 | 70.3 (2) | C6—C7—C3—N4 | −0.3 (2) |
N3—C1—C2—Cl1 | 66.78 (19) | C4—C7—C3—N4 | 178.7 (2) |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1···O1i | 0.86 | 1.96 | 2.810 (2) | 170 |
C5—H5A···N4ii | 0.93 | 2.79 | 3.676 (2) | 160 |
C2—H2A···Cl1iii | 0.97 | 2.84 | 3.779 (2) | 164 |
C2—H2B···N2iv | 0.97 | 2.59 | 3.463 (2) | 150 |
C3—H3···O1v | 0.93 | 2.35 | 3.254 (2) | 163 |
Symmetry codes: (i) −x+1, −y+2, −z+2; (ii) x, y+1, z; (iii) −x+3/2, y−1/2, −z+3/2; (iv) −x+5/2, y−1/2, −z+3/2; (v) −x+1, −y+1, −z+2. |
Experimental details
Crystal data | |
Chemical formula | C7H7ClN4O |
Mr | 198.61 |
Crystal system, space group | Monoclinic, P21/n |
Temperature (K) | 296 |
a, b, c (Å) | 4.6448 (1), 8.0792 (1), 22.7335 (4) |
β (°) | 93.554 (1) |
V (Å3) | 851.46 (3) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.41 |
Crystal size (mm) | 0.18 × 0.16 × 0.16 |
Data collection | |
Diffractometer | Bruker SMART APEX CCD detector |
Absorption correction | Multi-scan (SADABS; Bruker, 1998) |
Tmin, Tmax | 0.930, 0.937 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 7660, 1548, 1353 |
Rint | 0.023 |
(sin θ/λ)max (Å−1) | 0.600 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.035, 0.100, 0.87 |
No. of reflections | 1548 |
No. of parameters | 118 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.19, −0.37 |
Computer programs: SMART (Bruker, 1998), SAINT-Plus (Bruker, 1998), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), ORTEP-3 (Farrugia, 1997) and CAMERON (Watkin et al., 1996), WinGX (Farrugia, 1999).
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1···O1i | 0.860 | 1.958 | 2.810 (2) | 170 |
C5—H5A···N4ii | 0.930 | 2.789 | 3.676 (2) | 160 |
C2—H2A···Cl1iii | 0.970 | 2.836 | 3.779 (2) | 164 |
C2—H2B···N2iv | 0.970 | 2.587 | 3.463 (2) | 150 |
C3—H3···O1v | 0.930 | 2.353 | 3.254 (2) | 163 |
Symmetry codes: (i) −x+1, −y+2, −z+2; (ii) x, y+1, z; (iii) −x+3/2, y−1/2, −z+3/2; (iv) −x+5/2, y−1/2, −z+3/2; (v) −x+1, −y+1, −z+2. |
Acknowledgements
IMK is thankful to the University Grants Commission (UGC), India, for financial assistance.
References
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N. L. (1995). Angew. Chem. 34, 1555–1573. CrossRef CAS Google Scholar
Bruker. (1998). SMART, SAINT-Plus and SADABS. Bruker Axs Inc., Madison, Wisconcin, USA. Google Scholar
Carraro, F., Naldini, A., Pucci, A., Locatelli, G. A., Maga, G., Schenone, S., Bruno, O., Ranise, A., Bondavalli, F., Brullo, C., Fossa, P., Menozzi, G., Mosti, L., Modugno, M., Tintori, C., Manetti, F. & Botta|, M. (2006). J. Med. Chem. 49, 1549–1561. Google Scholar
Dolzhenko, A. V., Pastorin, G., Dolzhenko, A. V., Tan, G. K. & Koh, L. L. (2009). Acta Cryst. E65, o1720–o1721. Web of Science CSD CrossRef IUCr Journals Google Scholar
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565. CrossRef IUCr Journals Google Scholar
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837–838. CrossRef CAS IUCr Journals Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Watkin, D. J., Prout, C. K. & Pearce, L. J. (1996). CAMERON. Chemical Crystallography Laboratory, University of Oxford, England. Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Pyrazolo[3,4-d]pyrimidines are purine analogues which exhibit a number of pharmacological properties such as antitryproliferative (Carraro et al., 2006).
In the title compound (Fig. 1), the fused pyrazolopyrimidine ring is substituted with 2-chloro-ethyl group on one side and the oxo group on the other side. The pyrazolopyrimidine ring is planar with the maximum deviation from the mean statistical plane being 0.0115 (14) Å for C3. The cis orientation of 2-chloro-ethyl group with respect to the C2—N2 bond is described by the torsion angle N2—C2—N3—C3, -2.204 (4)°.
The crystal structure is stabilized by some interesting features that comprise of intermolecular N—H···O, C—H···O, C—H···N and C—H···Cl interactions (Fig. 2 and Tab. 1). The C—H···O and the N—H···O interactions result in centrosymmetric head-to-head dimers corresponding to the graph set R22(10) and R22(8) motif (Bernstein et al., 1995). There are two types of C—H···N interactions, one of which forms a helix, the other forms sheets along the crystallographic b-axis. The C—H···Cl intermolecular interaction result in one dimensional molecular chain along b-axis. The bond lengths and bond angles in the title molecule agree very well with the corresponding bond distances and bond angles reported in a closely related compound (Dolzhenko et al., 2009).